These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 26681776)
1. CipA of Acinetobacter baumannii Is a Novel Plasminogen Binding and Complement Inhibitory Protein. Koenigs A; Stahl J; Averhoff B; Göttig S; Wichelhaus TA; Wallich R; Zipfel PF; Kraiczy P J Infect Dis; 2016 May; 213(9):1388-99. PubMed ID: 26681776 [TBL] [Abstract][Full Text] [Related]
2. Translation Elongation Factor Tuf of Acinetobacter baumannii Is a Plasminogen-Binding Protein. Koenigs A; Zipfel PF; Kraiczy P PLoS One; 2015; 10(7):e0134418. PubMed ID: 26230848 [TBL] [Abstract][Full Text] [Related]
3. CipA mediates complement resistance of Ries JI; Heß M; Nouri N; Wichelhaus TA; Göttig S; Falcone FH; Kraiczy P Front Immunol; 2022; 13():942482. PubMed ID: 35958553 [TBL] [Abstract][Full Text] [Related]
4. Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins. Kim SW; Choi CH; Moon DC; Jin JS; Lee JH; Shin JH; Kim JM; Lee YC; Seol SY; Cho DT; Lee JC FEMS Microbiol Lett; 2009 Dec; 301(2):224-31. PubMed ID: 19878322 [TBL] [Abstract][Full Text] [Related]
5. Acinetobacter baumannii: an emerging multidrug-resistant threat. Gootz TD; Marra A Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496 [TBL] [Abstract][Full Text] [Related]
6. Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity. Runci F; Gentile V; Frangipani E; Rampioni G; Leoni L; Lucidi M; Visaggio D; Harris G; Chen W; Stahl J; Averhoff B; Visca P Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30718286 [No Abstract] [Full Text] [Related]
7. Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis. Bhuiyan MS; Ellett F; Murray GL; Kostoulias X; Cerqueira GM; Schulze KE; Mahamad Maifiah MH; Li J; Creek DJ; Lieschke GJ; Peleg AY Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9599-604. PubMed ID: 27506797 [TBL] [Abstract][Full Text] [Related]
8. 2-Hydroxylation of Bartholomew TL; Kidd TJ; Sá Pessoa J; Conde Álvarez R; Bengoechea JA Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30745327 [No Abstract] [Full Text] [Related]
9. Disruption of tetR type regulator adeN by mobile genetic element confers elevated virulence in Acinetobacter baumannii. Saranathan R; Pagal S; Sawant AR; Tomar A; Madhangi M; Sah S; Satti A; Arunkumar KP; Prashanth K Virulence; 2017 Oct; 8(7):1316-1334. PubMed ID: 28436748 [TBL] [Abstract][Full Text] [Related]
10. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. King LB; Swiatlo E; Swiatlo A; McDaniel LS FEMS Immunol Med Microbiol; 2009 Apr; 55(3):414-21. PubMed ID: 19220466 [TBL] [Abstract][Full Text] [Related]
11. Penicillin-binding protein 7/8 contributes to the survival of Acinetobacter baumannii in vitro and in vivo. Russo TA; MacDonald U; Beanan JM; Olson R; MacDonald IJ; Sauberan SL; Luke NR; Schultz LW; Umland TC J Infect Dis; 2009 Feb; 199(4):513-21. PubMed ID: 19143563 [TBL] [Abstract][Full Text] [Related]
12. Distribution of AdeABC efflux system genes in genotypically diverse strains of clinical Acinetobacter baumannii. Wieczorek P; Sacha P; Czaban S; Hauschild T; Ojdana D; Kowalczuk O; Milewski R; Poniatowski B; Nikliński J; Tryniszewska E Diagn Microbiol Infect Dis; 2013 Oct; 77(2):106-9. PubMed ID: 23886790 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital. Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594 [TBL] [Abstract][Full Text] [Related]
14. Quorum sensing in Acinetobacter: an emerging pathogen. Bhargava N; Sharma P; Capalash N Crit Rev Microbiol; 2010 Nov; 36(4):349-60. PubMed ID: 20846031 [TBL] [Abstract][Full Text] [Related]
15. Tug of war between Acinetobacter baumannii and host immune responses. Li FJ; Starrs L; Burgio G Pathog Dis; 2018 Dec; 76(9):. PubMed ID: 30657912 [TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Gordon NC; Wareham DW Int J Antimicrob Agents; 2010 Mar; 35(3):219-26. PubMed ID: 20047818 [TBL] [Abstract][Full Text] [Related]
18. Acinetobacter baumannii Is Dependent on the Type II Secretion System and Its Substrate LipA for Lipid Utilization and In Vivo Fitness. Johnson TL; Waack U; Smith S; Mobley H; Sandkvist M J Bacteriol; 2015 Dec; 198(4):711-9. PubMed ID: 26668261 [TBL] [Abstract][Full Text] [Related]
19. A Simplified Derivative of Human Defensin 5 with Potent and Efficient Activity against Multidrug-Resistant Acinetobacter baumannii. Wang C; Zhao G; Wang S; Chen Y; Gong Y; Chen S; Xu Y; Hu M; Wang X; Zeng H; Wang A; Liu D; Su Y; Cheng T; Chen F; Wang J Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158275 [TBL] [Abstract][Full Text] [Related]
20. Acinetobacter: an emerging pathogen with a versatile secretome. Elhosseiny NM; Attia AS Emerg Microbes Infect; 2018 Mar; 7(1):33. PubMed ID: 29559620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]